Bicara Therapeutics Inc. (BCAX) stock
BCAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$8.44−0.68 (-7.46%)
Close on Nov 20, 2026Market cap $558.50MP/E –Yield –
Bicara Therapeutics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Bicara Therapeutics's shares outstanding was 68M at Sep 30, 2026. For fiscal 2025 it was 54.68B, up 225.4% from the year before.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 54.68B | +225.4% |
| FY2024 | Dec 31, 2024 | 16.81B | +2797.0% |
| FY2023 | Dec 31, 2023 | 580M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 68M | +25.4% |
| Q2 FY2026 | Jun 30, 2026 | 68M | +24.7% |
| Q1 FY2026 | Mar 31, 2026 | 61M | +457.0% |
| Q3 FY2025 | Sep 30, 2025 | 55M | +5984.7% |
| Q2 FY2025 | Jun 30, 2025 | 55M | +8159.9% |
| Q1 FY2025 | Mar 31, 2025 | 54M | +9012.7% |
| Q3 FY2024 | Sep 30, 2024 | 11M | – |
| Q2 FY2024 | Jun 30, 2024 | 1M | – |
| Q1 FY2024 | Mar 31, 2024 | 1M | – |
| Q3 FY2023 | Sep 30, 2023 | 1M | – |
See a number that looks wrong?